Efmoroctocog alfa, sold under the brand name Elocta among others, is a medication for the treatment and prophylaxis of bleeding in people with hemophilia...
8 KB (387 words) - 09:35, 6 August 2024
Factor VIII (medication) (redirect from Octocog alfa)
Damoctocog alfa pegol, a recombinant antihemophilic factor VIII Efmoroctocog alfa, a recombinant antihemophilic factor VIII Moroctocog alfa, a recombinant...
19 KB (840 words) - 02:55, 14 August 2024
intrinsic: VIII/(Damoctocog alfa pegol, Efanesoctocog alfa, Efmoroctocog alfa, Moroctocog alfa, Susoctocog alfa, Turoctocog alfa, Valoctocogene roxaparvovec)...
9 KB (964 words) - 13:43, 15 November 2022
(PDF). Wyeth Pharmaceuticals Inc. Frampton JE (September 2016). "Efmoroctocog Alfa: A Review in Haemophilia A". Drugs. 76 (13): 1281–1291. doi:10...
8 KB (547 words) - 19:59, 20 December 2023